0001179110-15-001059.txt : 20150120
0001179110-15-001059.hdr.sgml : 20150119
20150120161005
ACCESSION NUMBER: 0001179110-15-001059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150116
FILED AS OF DATE: 20150120
DATE AS OF CHANGE: 20150120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALERE INC.
CENTRAL INDEX KEY: 0001145460
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 043565120
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7816473900
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: INVERNESS MEDICAL INNOVATIONS INC
DATE OF NAME CHANGE: 20010720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flakne Carla
CENTRAL INDEX KEY: 0001600843
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16789
FILM NUMBER: 15536093
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02474
4
1
edgar.xml
FORM 4 -
X0306
4
2015-01-16
0
0001145460
ALERE INC.
ALR
0001600843
Flakne Carla
51 SAWYER ROAD, SUITE 200
WALTHAM
MA
02453
0
1
0
0
VP, Chief Accounting Officer
Common Stock
2014-11-07
5
G
0
E
380
0
D
3011
D
Common Stock
2015-01-16
4
M
0
10000
23.15
A
13252
D
Common Stock
2015-01-16
4
S
0
10000
42.445
D
3252
D
Common Stock
462
I
See Footnote
Employee Stock Option (Right to Buy)
23.15
2015-01-16
4
M
0
10000
D
2015-12-14
Common Stock
10000
0
D
Includes 248 shares acquired under the Alere Inc. Employee Stock Purchase Plan on June 30, 2014.
The transactions reported on this Form were made pursuant to a written 10b5-1 trading plan adopted in accordance with SEC Rule 10b5-1. Represents same day exercise and sale of expiring stock options.
Includes 241 shares acquired under the Alere Inc. Employee Stock Purchase Plan on December 31, 2014.
The price reported is a weighted average price. These shares were sold in approximately 68 separate transactions at prices ranging from $41.81 to $42.82, inclusive. The reporting person hereby undertakes to provide to the SEC, the issuer or any stockholder of the issuer, upon request, the full information regarding the number of shares and prices at which the transaction was effected.
Option vested in four equal installments on 12/14/06, 12/14/07, 12/14/08 and 12/14/09.
This derivative security does not have a price.
These securities are owned by the 2012 Flakne Family Trust, for which the reporting person & her spouse are the trustees.
/s/ Jay McNamara, attorney-in-fact
2015-01-20